MMP2 and ovarian carcinoma: Additionally, the authors, in their investigations on cervical and ovarian cancer cells, observed a Pug-induced reduction in matrix metalloproteinases (MMP2 and 9) paralleled by a rise in their inhibitors (TIMP2 and 3).